
US dismisses India's steel tariff challenge at WTO on legal, procedural grounds
The United States has rejected India's notice at the World Trade Organization (WTO), which proposed retaliatory action against the 25 per cent US tariffs on steel and aluminium, arguing that the tariffs were imposed on national security grounds. The US also pointed out procedural errors in India's case.
In its note dated May 23, the US stated that India is wrongly treating the tariffs on steel and aluminium as safeguard measures. It clarified that these duties were imposed under US law (Section 232), which allows such action if imports are considered a threat to national security.
This development is significant as US President Donald Trump on Friday announced a move to double import tariffs on steel to 50 per cent — a step Indian exporters have called 'unfortunate', warning that they have already lost $5 billion in exports due to earlier tariffs, and further hikes could deepen losses.
'The United States will not discuss the Section 232 tariffs under the Agreement on Safeguards as we do not view the tariffs as a safeguard measure,' the US told the WTO Council for Trade in Goods in response to India's challenge.
In FY2025, India exported $4.56 billion worth of iron, steel, and aluminium products to the US, including $587.5 million in iron and steel, $3.1 billion in articles of iron or steel, and $860 million in aluminium and related goods. These exports now face sharply higher US tariffs, threatening the profitability of Indian producers and exporters.
The US also claimed that India had committed procedural errors. 'India never acknowledged the United States' offer to discuss these tariffs in our response dated 16 April 2025. Accordingly, India has not complied with the obligations under the Agreement on Safeguards, the agreement that it mistakenly contends applies to the tariffs in question,' the US note said.
Ajay Srivastava, former trade officer and head of the Global Trade Research Initiative (GTRI), said India now has several options. One is to launch a formal WTO dispute, not under the Safeguards Agreement, but under broader GATT rules, challenging the Section 232 tariffs as disguised protectionist measures.
'India could argue that the US is abusing the national security exception, referring to earlier WTO rulings that limit how Article XXI can be invoked. However, this legal path carries risks, as the US has a track record of disregarding WTO rulings on national security,' GTRI said.
A more forceful approach would be for India to impose retaliatory tariffs on its own, even without WTO authorisation, Srivastava said. He noted that other countries such as the EU, Canada, and China have already done this in response to the US Section 232 tariffs, as a political signal of resistance.
'While this sends a clear message, it also risks US countermeasures and potential legal battles. GTRI believes that although India has legal and diplomatic options, it may decide not to act immediately,' Srivastava said. GTRI suggested that a pragmatic path would be for India to use the ongoing bilateral Free Trade Agreement (FTA) negotiations with the US as the main platform to resolve the issue.
Ravi Dutta Mishra is a Principal Correspondent with The Indian Express, covering policy issues related to trade, commerce, and banking. He has over five years of experience and has previously worked with Mint, CNBC-TV18, and other news outlets. ... Read More
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Indian Express
27 minutes ago
- Indian Express
A father-son legacy of Padma honors and pioneering scientific research
Written by Siddhi Patil, Dr Chetan Eknath Chitnis, a globally renowned Indian scientist, has dedicated his life to combating malaria, a persistent global health challenge claiming countless lives annually. His groundbreaking work in malaria vaccine development has earned him the prestigious Padma Shri this year, alongside awards like the Shanti Swarup Bhatnagar Award and the Infosys Prize. Remarkably, Dr. Chitnis shares a rare distinction with his father, Eknath Vasant Chitnis, a Padma Bhushan recipient (1985) and a founding member of the Indian Space Research Organisation (ISRO). This rare father-son duo's Padma honors reflect a deep family legacy of scientific excellence, with both making transformative contributions to their respective fields. Dr. Chitnis's journey in medical research is deeply rooted in his upbringing. His father, a distinguished space scientist and former director of ISRO's Space Application Centre, instilled a passion for dedicated work. 'My father taught me that true commitment means loving what you do, no matter the hours,' Dr. Chitnis recalls. While he initially pursued physics, inspired by his father's rigor, it was his mother, a biochemist focused on cancer research, who steered him toward biology. This pivot led him to lead the Malaria Parasite Biology and Vaccines Unit at Institut Pasteur in Paris, where he drives innovative vaccine research to curb malaria's devastating impact. Pune holds a special place in Dr. Chitnis's heart. Childhood summers spent at his grandparents' home in Deccan Gymkhana, exploring nearby hills with cousins, evoke memories of a serene, green Pune. His parents' decision to settle in the city post-retirement deepened his connection. Today, as Pune evolves into a bustling hub of innovation, Dr. Chitnis is eager to engage with its academic and research communities, blending personal nostalgia with professional aspirations. From IIT Bombay to UC Berkeley, the National Institutes of Health, and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi, Dr. Chitnis's career spans continents. His work at ICGEB, supported by robust government backing, laid the foundation for his current efforts in Paris. A significant breakthrough came during the COVID-19 pandemic when delayed vaccine trials at Oxford revealed that a 14-month gap between doses reduced malaria parasite growth—an unexpected finding inspired by similar COVID-19 vaccine insights. This discovery, coupled with advancements in mRNA technology, fuels his cautious optimism for future malaria solutions. The Padma Shri holds deep significance for Dr. Chitnis. 'Being recognised by my homeland, even after a decade abroad, is humbling,' he says. He views the award as a tribute to his team's collective efforts and a call to continue serving society.


Time of India
27 minutes ago
- Time of India
TN Govt allows early morning release for Haasan's movie 'Thug Life' amid language row
The Tamil Nadu government on Wednesday granted permission to the makers of 'Thug Life', the much-anticipated film by veteran film-maker Mani Ratnam and superstar Kamal Haasan , to hold special early morning screenings on the day of its release - Thursday, June 5. The decision was made following a formal request submitted by Raaj Kamal Films International, Kamal Haasan's production house backing the movie. According to the government's order, the film will be allowed to have five shows on the day of release, with the first show beginning at 9 a.m. on Thursday and the last one concluding by 2 a.m. on Friday. Special screenings outside the standard time slots are typically granted to big-budget or high-profile films in Tamil Nadu , particularly when led by popular stars or renowned film-makers. The announcement, however, comes at a time when 'Thug Life' is facing controversy over a statement made by Kamal Haasan during the film's audio launch. The actor-politician claimed that "Kannada is born out of Tamil," a remark that sparked strong reactions in Karnataka . The Karnataka High Court recently suggested that Kamal issue an apology, but the star has refused to do so. However, the superstar wrote a letter to the Karnataka Film Chamber of Commerce on Tuesday stating that the row over his remarks on origins of Kannada language is a result of a misunderstanding. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Council or Housing Association Tenant? Check Eligibility for Compensation National Disrepair Claims Undo In his letter, Kamal Haasan also maintained that he is against the dominance of one language over another. As a result of the actor's refusal to issue an outright apology, the film's release in Karnataka has been postponed indefinitely. Kamal Haasan Faces Ban in Karnataka Over Kannada Language Row, Minister Demands Apology | Thug Life Despite the controversy, 'Thug Life' is one of the most anticipated Tamil films of the year. The project marks the reunion of Kamal Haasan and Mani Ratnam after nearly four decades, following their legendary 1987 collaboration 'Nayakan', considered a milestone in Indian cinema. The gangster drama features a star-studded cast, including Silambarasan T.R. in a key role, alongside Trisha, Nasser, Joju George, Abhirami, Ashok Selvan, Aishwarya Lekshmi , Sanya Malhotra, and Ali Fazal. The music for the film has been composed by Academy Award-winner A.R. Rahman, further adding to the excitement around the release. 'Thug Life' is a joint production of Raaj Kamal Films International and Mani Ratnam's Madras Talkies, and will be distributed by Red Giant Movies. With high expectations from fans and film critics alike, the movie's performance at the box office - particularly in Tamil Nadu - will be closely watched as it hits the screens tomorrow. Check out our list of the latest Hindi , English , Tamil , Telugu , Malayalam , and Kannada movies . Don't miss our picks for the best Hindi movies , best Tamil movies, and best Telugu films .


Time of India
27 minutes ago
- Time of India
India weighs legal uncertainties around Trump tariffs as trade pact talks start this week
India is weighing legal uncertainties surrounding Trump tariffs as it prepares for the next round of trade talks this week, an official said. The official said these developments could influence India's approach to the proposed bilateral trade pact with the US. A team of US officials is visiting here from June 5 to hold talks with their Indian counterparts on the proposed pact. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like O novo dispositivo que os idosos usam para ajudar na neuropatia (dor nos nervos) A arte do herbalismo Undo Though India is looking for a balanced and a mutually beneficial trade agreement with the US, "what we get as compared to other countries, will determine what we ultimately finalise in the deal", the official said. The US is negotiating trade pacts with over 75 countries, including China. It has already finalised a pact with the UK. Live Events Asked if some kind of interim trade deal can be agreed upon before July 9, the official said a lot of uncertainties are there at present because of developments like the Trump administration's plan to further increase tariffs on steel and a stay on a court order against the US authorities' decisions on tariffs. But within the constraints of uncertainties, India has to find pathways which are good for the country, the official added. A US court of international trade on May 28 had ruled that present Trump tariffs were illegal under the international emergency economic powers act. The administration later filed an appeal and got a stay on this order. On April 2, US President Donald Trump announced reciprocal tariffs against several countries, including India. It imposed an additional duty of 26 per cent on India, but later suspended it till July 9. However, the 10 per cent baseline duty on all the countries remains. India has already reserved its right to impose retaliatory tariffs against US duties on steel and aluminium. It has also sought consultations under the WTO norms on US tariffs on auto components. If India is considering taking similar measures in more products, the official said India will protect its interests. "We will see what is good for India... accordingly we will take decisions," the official said, adding, "Today a lot of uncertainties are there... because of that court order... we will discuss how to address these issues... lot of uncertainties are there".